Innoveren Scientific Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	0.1	1.64	1.42	0.07	0.25	0.9	1.57	6.68
Cash & Cash Equivalents	0.1	1.64	1.42	0.07	0.25	0.9	1.57	6.68
Cash Growth	-94.20%	15.21%	1945.29%	-71.90%	-72.33%	-43.06%	-76.47%	-
Receivables	0.12	0.02	0.04	0.02	0.39	0.15	0	0
Inventory	0	0	0	0	0.29	0	0	0
Other Current Assets	-0.02	0.09	0.81	0.06	0.2	0.21	0.2	0.16
Total Current Assets	0.2	1.76	2.28	0.15	1.14	1.26	1.77	6.84
Property, Plant & Equipment	0.04	0.42	0.96	0.27	0.09	0.1	0.02	0.02
Goodwill and Intangibles	0	0	0	0	0	0	6.46	0
Other Long-Term Assets	0.09	0.03	0.04	0.04	0	0.15	3.28	0
Total Long-Term Assets	0.12	0.45	1	0.31	0.09	0.25	9.76	0.02
Total Assets	0.32	2.2	3.27	0.45	1.23	1.51	11.53	6.87
Accounts Payable	0.68	1.01	1.49	0.88	0.21	0.23	0.26	0
Deferred Revenue	0.41	0.63	1.05	0.33	0	0	0	0
Current Debt	3.46	0.67	2.13	0.18	0.13	1.1	0.13	0
Other Current Liabilities	0.36	0.58	1.12	0.8	0.13	0.53	0.2	0.36
Total Current Liabilities	4.92	2.89	5.77	2.19	0.48	1.85	0.59	0.36
Long-Term Debt	0.06	0.36	0.31	4.31	0.04	0.1	0.92	0
Other Long-Term Liabilities	0	0	0.58	0.02	0	0	0	0
Total Long-Term Liabilities	0.06	0.36	0.9	4.33	0.04	0.1	0.92	0
Total Liabilities	4.98	3.25	6.67	6.52	0.51	1.96	1.51	0.36
Total Debt	3.52	1.03	2.44	4.49	0.17	1.2	1.05	0
Debt Growth	240.90%	-57.64%	-45.61%	2519.22%	-85.73%	13.95%	-	-
Retained Earnings	-49.03	-44.23	-37.36	-9.3	-32.82	-26.36	-10.13	-3.61
Shareholders' Equity	-4.66	-1.05	-9.09	-5.7	0.71	-0.45	10.02	6.51
Net Cash / Debt	-3.43	0.61	-1.02	-4.42	0.08	-0.3	0.52	6.68
Net Cash / Debt Growth	-	-	-	-	-	-	-92.22%	-
Net Cash Per Share	-23.52	5.45	-10.54	-131.21	4.00	-22.98	47.49	846.47
Working Capital	-4.72	-1.14	-3.5	-2.04	0.66	-0.59	1.19	6.48
Book Value Per Share	-31.99	-9.40	-94.33	-169.23	37.27	-33.81	915.85	823.80

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).